WARPTECHNEWS · LAB

Home AI Business Tech Archive

WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

Home
Archivio
Editor's Brief
Cerca
Il tuo account
Newsletter tech/AI

Informazioni legali

Privacy Policy
Termini di servizio
Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Storia in 3 fonti

Prime wins Beam arbitration, clearing path to clinic

AstraZeneca, Ionis report major trial failure, White House pushes for American drug manufacturing, and more biotech news from The Readout

Raccontata da

fiercepharma.com

Confronto fonti

3 prospettive sulla stessa storia

AI · summaries

statnews.comStai leggendo1 g fa

Prime wins Beam arbitration, clearing path to clinic

AstraZeneca, Ionis report major trial failure, White House pushes for American drug manufacturing, and more biotech news from The Readout

endpoints.news2 g fa

Prime Medicine wins spat with Beam Therapeutics over AATD candidate

Prime Medicine wins arbitration vs Beam Therapeutics, plans FDA IND filing for genetic liver disease treatment. $PRME stock rises 12%.

Leggi questa versione → originale

Timeline cronologica

mercoledì 8 luglio 2026·endpoints.news
Prime Medicine wins spat with Beam Therapeutics over AATD candidate
Prime Medicine wins arbitration vs Beam Therapeutics, plans FDA IND filing for genetic liver disease treatment. $PRME stock rises 12%.
giovedì 9 luglio 2026·statnews.com
Prime wins Beam arbitration, clearing path to clinic
AstraZeneca, Ionis report major trial failure, White House pushes for American drug manufacturing, and more biotech news from The Readout

fiercepharma.com11 h fa

A $10B deal, China trial scrutiny and highlights from ADA 2026

This week on "The Top Line," we’re covering some of the biggest stories across biopharma before turning to one of the industry’s major scientific meetings of the summer. | This week on "The Top Line," we’re covering…

Leggi questa versione → originale

venerdì 10 luglio 2026·

fiercepharma.com

A $10B deal, China trial scrutiny and highlights from ADA 2026

This week on "The Top Line," we’re covering some of the biggest stories across biopharma before turning to one of the industry’s major scientific meetings of the summer. | This…

venerdì 10 luglio 2026·

statnews.com

Roche ends Huntington's gene-silencing programs

ARPA-H launches bespoke gene therapy push, Lilly and Novo to promote Bridge program, and more biotech news from The Readout